Key result
Prescription of beta blockers at discharge after acute myocardial infarction was associated with significantly lower 1-year mortality compared to no prescription (11% vs 27%, p<0.001).
Why the study?
Does prescription of beta blockers at discharge reduce 1-year mortality in survivors of acute myocardial infarction?
Population
Survivors of acute myocardial infarction admitted to Sahlgren's Hospital between February 15, 1986, and…
Comparison
Prescription of beta blockers at discharge vs No prescription of beta blockers at discharge
Design
Cohort
Follow-up
1 year
Authors
Loading...
Associated with lower post-MI mortality in this cohort; leaves open causality and requires RCTs before practice change.
Cohort
No
Does prescription of beta blockers at discharge reduce 1-year mortality in survivors of acute myocardial infarction?
Absolute Event Rate: 11% vs 27%
p-value: p=<0.001
Prescription of beta blockers at discharge after acute myocardial infarction is associated with a significantly increased rate of 1-year survival.
Karlson et al. (1994) conducted a cohort in Acute myocardial infarction. Beta blockers vs. No beta blockers prescribed at discharge was evaluated on 1-year mortality (p=<0.001). Prescription of beta blockers at discharge after acute myocardial infarction was associated with significantly lower 1-year mortality compared to no prescription (11% vs 27%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: